Osteoartritis. Arthrosis, unspecified
Conditions
Interventions
Intervention 1: The first group received placebo gel topically 3 times a day with 200 mg celecoxib capsules for oral use. Intervention 2: The Second group received Thymus daenensis extract gel 5% gel
Treatment - Drugs
The first group received placebo gel topically 3 times a day with 200 mg celecoxib capsules for oral use
The Second group received Thymus daenensis extract gel 5% gel topically 3 times a day with 200 mg celecoxib capsules for oral use
The Third group received diclofenac gel 1% gel topically 3 times a day with 200 mg celecoxib capsules for oral use
Sponsors
Vice chancellor for research of Shahrekord University of Medical Science
Eligibility
Sex/Gender
All
Age
45 Years to 75 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 45_75 years old; a definitive diagnosis of osteoarthritis disease with specialist Exclusion criteria: severe diseases such as metabolic disorders and digestive at the same time; severe infection, sensitivity to thyme extract daenensis, pregnancy, lactation, impaired liver function tests; history of fracture or knee surgery; rheumatoid arthritis
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improving physical Function. Timepoint: Baseline and Six Weeks later. Method of measurement: WOMAC questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain relief. Timepoint: Baseline and Six Weeks later. Method of measurement: VAS questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMorteza Dehghan
Shahrekord University of Medical Scienties
Outcome results
None listed